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Abstract
The biocompatibility and antibacterial properties of N,N-hexyl,methyl-polyethylenimine (HMPEI)
covalently attached to the Boston Keratoprosthesis (B-KPro) materials was evaluated. By means
of confocal and electron microscopies, we observed that HMPEI-derivatized materials exert an
inhibitory effect on biofilm formation by Staphylococcus aureus clinical isolates, as compared to
the parent poly(methyl methacrylate) (PMMA) and titanium. There was no additional corneal
epithelial cell cytotoxicity of HMPEI-coated PMMA compared to that of control PMMA in tissue
cultures in vitro. Likewise, no toxicity or adverse reactivity was detected with HMPEI-derivatized
PMMA or titanium compared to those of the control materials after intrastromal or anterior
chamber implantation in rabbits in vivo.
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1. Introduction
Indwelling prosthetic devices have been critical in saving numerous lives and they have
enhanced the quality of life for even more patients [1]. Yet the presence of an indwelling
foreign body both predisposes to, and complicates the eradication of, infections, often with
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biofilm formation [2]. Device-related biofilm infections account for some 60% of all
hospital-associated infections [3] and add about $5 billion per year to U.S. hospital costs [4].
Biofilms, heterogenous collections of bacteria often encased by a secreted matrix called
extracellular polymeric substance (EPS) [5], adhere strongly to surfaces, are resistant to
antibiotics and other biocides, and are protected from host immune defenses [6]. The risk of
a biofilm-associated medical device infection depends on its location, with any implantable
device that translocates from the surface of the body (skin, cornea) into a sterile body site
(blood, urine, intraocular) being at greater risk [2,7].
The Boston Keratoprosthesis (B-KPro) is an artificial cornea that is a treatment option for
corneal disorders not amenable to standard penetrating keratoplasty (corneal transplantation)
[8]. The B-KPro has the shape of a collar button and consists of a transparent medical-grade
poly(methyl methylacrylate) (PMMA) front plate with a stem, that houses the optical portion
of the device, and a back plate with holes composed of either PMMA or medical-grade
titanium. During implantation, the device is assembled with a donor corneal graft positioned
between the front and back plates with extension of the optic stem into the anterior chamber
of the eye; a titanium C-ring locks the assembly (Figs. 1A to 1C) [9]. Its postoperative
management includes the continuous wearing of a soft contact lens to prevent ocular surface
dehydration and tissue melt [10]. Daily low-dose topical antibiotic prophylaxis is required
[11], as well as low-dose topical steroids in many patients [9]. While the use of life-long
daily antibiotic prophylaxis to prevent infection has been effective, long-term medication
adherence and emergence of resistant organisms continue to be concerns, especially in the
developing world [12].
Thus there is a great need for keratoprostheses and other implantable medical devices that
inherently resist bacterial infection long-term. Most biocidal products depend on a timed
release of antibiotics, heavy metal ions (notably silver), or other biocides. Once all biocide
has been released, the antimicrobial activity ends, leaving foreign material in situ;
consequently, the overall long-term benefit of antibiotic-impregnated materials remains
unclear [13]. Given the large health care costs of medical-device and hospital-acquired
infections [4], non-toxic materials that effectively and permanently limit microbial
adherence and viability are very much needed.
It would be most desirable to permanently attach coatings onto PMMA and other currently
used prosthetic materials that either prevent adherence of bacteria or kill them on contact,
thereby inhibiting the formation of biofilms. Recently, non-leaching, long-chained
hydrophobic polycations that can be attached covalently to the materials' surfaces and render
them strongly antimicrobial have been developed [14,15]. Specifically, immobilized N,N-
hexyl,methyl-polyethylenimine (HMPEI) (Fig. 1D) has broad antibacterial, antifungal, and
antiviral properties [16-19].
Herein we assess HMPEI covalently attached to PMMA and titanium materials used in the
construction of the B-KPro. Antimicrobial efficacy against hyperbiofilm-forming clinical
isolates of Staphylococcus aureus and in vitro cell cytotoxicity using immortalized human
corneal epithelial cells were investigated. In vivo biocompatibility studies with new ocular
models in the rabbit comparing HMPEI-derivatized and parent PMMA and titanium, as well
as the B-KPro with applicability to other implantable medical devices, were examined.
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2. Materials and Methods
2.1 Materials
Laboratory chemicals, branched 750-kDa PEI [19], 500-kDa poly(2-ethyl-2-oxazoline), and
organic solvents were from Sigma-Aldrich Chemical Co. (St. Louis, MO). Linear PEI (217
kDa) was prepared by deacylation of poly(2-ethyl-2-oxazoline) as previously described [19].
The Boston Keratoprosthesis (B-KPro) parent materials were medical-grade poly(methyl
methacrylate) (PMMA) (Spartech Townsend, Pleasant Hill, IA) and titanium (Ti) 6-4 ELI
(Dynamet, Washington, PA) processed by J.G. Machine Co (Woburn, MA). PMMA discs
were cut from a 1 cm rotating PMMA rod in 200- and 150-micron thickness. Smaller
PMMA discs (3, 1.5, and 1.0 mm) were punched out using Micro Punch Set (Micro-Mark,
www.micromark.com). Titanium discs (10, 3.0, and 1.0 mm in diameter) were punched
from a single Ti sheet (150 micron in thickness). KPro front pieces (KPro-FP) were made of
either a large (KPro-FP-L) 4.75 mm front plate diameter and 3.3 mm stem diameter or a
smaller (KPro-FP-S) 2.7 mm front plate diameter and 1.5 mm stem diameter; all had a 2 mm
stem length. B-KPro Type I threaded design (pseudophakic) had a front plate diameter of
5.0 mm and a stem diameter of 3.35 mm. The PMMA threaded back plate had a diameter of
8.5 mm, plate thickness of 0.8 mm, and 16 holes of 1.2 mm in diameter each. The daily wear
contact lens was composed of nelfilcon A (Focus Dailies™, diameter of 13.8 mm; CIBA
Vision Co., Duluth, GA). The bandage contact lens was composed of methafilcon (Kontur
Precision Sphere, diameter of 16 mm, base 8.6-9.8; Kontur Kontact Lens, Hercules, CA).
Povidone-iodine ophthalmic solution 5% (Betadine 5%™, Alcon, Fort Worth, TX) was used
as a preoperative antiseptic. Polymyxin B (10,000 polymyxin B U/mL and 1 mg
trimethoprim sulfate) ophthalmic solution USP with benzalkonium chloride 0.004%
preservative (Bausch & Lomb, Tampa, FL) and prednisolone acetate ophthalmic solution
1% (Falcon Pharmaceuticals (Alcon), Fort Worth, TX) were obtained from the
Massachusetts Eye and Ear Infirmary (MEEI) Pharmacy. Balanced salts solutions (BSS™
and BSS Plus™, Alcon) were used for ocular irrigation. Xylazine injectable solution 100
mg/mL (Tranquived, Vedco, St. Joseph, MO), ketamine HCl USP 100 mg/mL (Ketaject™,
Phoenix Pharm, St. Joseph, MO), and proparacaine HCl ophthalmic solution USP 0.5%
(Bausch & Lomb) were used as anesthetic agents. Pentobarbital solution 390 mg/mL (Fatal-
Plus, Vortech Pharm, Dearborn, MI) was used for euthanasia.
The surgical dissecting instruments were Super Sharp Blade, 30 degree, 3.5 mm (K-blade,
Katena Products, Denville, NJ), crescent microsurgical knife 2.0 mm angled, bevel up blade
(Katena Products), Graefe micro dissecting knife, 0.5 mm tip diameter (Fine Science Tools,
Vancouver, British Columbia, Canada), trephine 8.5mm (Storz Instruments, Bausch &
Lomb), and 3 mm and 1.5 mm biopsy punches (Acu-Punch, Acuderm, Ft. Lauderdale, FL).
Black monofilament nylon (Ethilon™ 10-0 and 8-0) and coated polyglactin 910 (Vicryl™
undyed braided 6-0) were used for suturing (Ethicon (Johnson & Johnson), Somerville, NJ).
2.2 Strains and Media
Because Staphylococcus aureus is a normal commensal on the skin and ocular surface, yet
infection (including device-associated biofilm infections [3]) appears to be predominantly
caused by a subset of organisms that possess certain microbiologic virulence traits [20-23],
we first screened infection-causing S. aureus clinical isolates for their ability to form
biofilms. Since previous reports have indicated the influence of media composition on in
vitro biofilm production, we evaluated our clinical isolates for biofilm production under
various media and growth conditions (Table 1).
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Fourteen S. aureus clinical isolates, including methicillin-sensitive and methicillin-resistant
ones, were obtained from the MEEI Porter Bacteriology Laboratory [24]. They were frozen
within two passages to minimize loss of in vivo virulence from representative eye, skin, and
mucous membrane infections. Three well-characterized S. aureus strains (gift of Dr. G. Pier,
Channing Lab, Boston, MA) [25] served as biofilm controls: (i) MN8 [26], a toxic shock
syndrome clinical isolate, that produces moderate amount of biofilm (MN8 mucoid,
MN8m); (ii) a spontaneous mutant isolated from a chemostat culture of MN8 that
constitutively overproduces the polysaccharide intercellular adhesion [poly(N-acetyl-1,6-
glucosamine)], a hyperbiofilm strain; and (iii) an isogenic mutant, MN8mΔica(x02237)tet,
containing a deletion in the ica locus which impairs biofilm formation. Minimal inhibitory
concentrations (MIC) were determined on planktonic bacteria by Clinical Standards and
Laboratory Institute methods [27]. Strains were evaluated for biofilm production in three
antibiotic-free media (brain heart infusion (BHI), trypticase soy broth (TSB), and Luria-
Bertani (LB)), with various carbohydrate sources (glucose and sucrose) and concentrations,
and at different time points.
2.3 Material Derivatizations
Linear and branched N,N-dodecyl,methyl-PEIs (DMPEIs) (from 217-kDa PEI), synthesized
as previously described [19], were used only for initial in vitro biofilm studies. PMMA discs
were painted with DMPEI dissolved in butanol (50 mg/mL) by brush coating both sides
three times.
Surface covalent modifications of PMMA and titanium materials, including the B-KPro, for
microscopy, cytotoxicity, and all in vivo studies employed linear N,N-hexyl,methyl-PEI
(HMPEI).
Covalent derivatization of PMMA [28] was performed as schematically illustrated below.
In Step 1, PMMA discs were treated with 4 M NaOH at 50°C for 90 min, washed, and
incubated in 10% aqueous citric acid overnight. The discs obtained in Step 1 were washed
with water until the pH of the washings became neutral, followed by air-drying. In Step 2,
the partially surface-hydrolyzed PMMA discs were treated with a 1:1 (v/v) DMF/water
solution containing 1.2 g of linear PEI, 4.5 g of 1-hydroxybenzotriazole, and 4.5 g of (3-
(dimethylamino)propyl)ethyl-carbodiimide HCl. Following a 18-h incubation at room
temperature, the discs were thoroughly washed with water and dried in air. In Step 3, PEI-
modified PMMA discs from Step 2 were treated with a 6:6:3.5 (v/v) mixture of 1-
bromohexane, triethylamine, and tert-amyl alcohol at room temperature for 3 h and then
thoroughly washed. In Step 4, they were treated with a 1:1 (v/v) mixture of iodomethane and
tert-amyl alcohol for 1 h, followed by washing with water and methanol. PMMA back plates
and screws were covalently derivatized with N,N-hexyl,methyl-PEI in the same manner. To
quantify the quaternary ammonium groups on the surface of the derivatized PMMA discs,
they were titrated with fluorescein [18]. The typical quaternary ammonium group surface
density was in the range from 3.4 to 4.7 nmoles per square centimeter.
Covalent modification of titanium discs [29] was performed as schematically shown below.
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In Step 1, Ti disks were rinsed with toluene and treated at 25°C for 2 h with a 1:1 (v/v)
mixture of concentrated H2SO4 and 30% aqueous H2O2. The cleaned and oxidized samples
were then rinsed with water and dried under vacuum. In Step 2, the surface-oxidized disks
were silanized [29] by heating them for 4 h in refluxing toluene containing 10% (3-
aminopropyl)triethoxysilane, followed by rinsing with toluene and drying under vacuum. In
Step 3, the silanized Ti discs were treated with 4-bromobutyryl chloride in chloroform at
room temperature for 5 h and then washed with chloroform to remove any remaining
acylating agent. In Step 4, the discs from Step 3 were treated with a solution of 1 g of linear
PEI and 90 mg of KOH in 10 mL of tert-amyl alcohol at 70°C for 12 h, followed by washing
with water and methanol and drying under vacuum. In Step 5, the discs from Step 4 were
first treated with a solution of 1.2 mL of 1-bromohexane and 90 mg of KOH in 8 mL of tert-
amyl alcohol at room temperature, followed by washing with water and methanol and drying
under vacuum, and then further alkylated with 1 mL of iodomethane in 4 mL of tert-amyl
alcohol.
The covalent modification of contact lenses (nelfilcon and methafilcon) was carried out by
modifying the hydroxyl groups on the surface with 4-bromobutyryl chloride, followed by
the reaction with PEI and alkylation with hexyl bromide and methyl iodide. The
modification of the contact lenses needs further optimization in order to minimize drying
and refinements will continue.
2.4 Cleaning and Sterilization
All materials were washed in a mild detergent with ultrasonic bath cleaning, rinsed
thoroughly with distilled water, and ethanol dried. Materials were sterilized by ethylene
oxide at 37°C.
2.5 Confocal Scanning Light Microscopy
To assess in vitro S. aureus biofilm formation and adherence, overnight cultures were grown
from a freshly streaked single colony in BHI-2% sucrose, back diluted 100-fold, and
aliquoted onto 1-cm sterile discs (HMPEI-PMMA and PMMA; HMPEI-Ti and Ti) in 24-
well cell culture dishes for 24 h and 6 days under static growth conditions at 37°C.
Samples were washed with 0.9% NaCl, stained with acridine orange, affixed to a small clear
plastic Petri dish, and examined using a Leica TCS-SP2 confocal scanner connected to an
inverted microscope (Leica Microsystems, Heidelberg, Germany). For 100X oil-immersion
objective, 0.9% NaCl was added to the Petri dish. 3-D confocal images and sequential scans
at 488 and 568 nm were obtained. Due to the autofluorescence of HMPEI coated-materials,
a third channel, at 633 nm, was added. One-micron sequential scans were obtained from four
predetermined representative areas. These experiments were performed in triplicate on
separate days.
2.6 Field Emission Scanning Electron Microscopy
In vitro S. aureus biofilm samples were grown as described in the preceding section. Both in
vitro and in vivo samples were fixed with ½ strength Karnovsky's solution, dehydrated
through a graded ethanol series, critical-point dried (Autosamdri 795 Supercritical Point
Dryer, Tousimis, Rockville, MD), and mounted and sputter coated with chromium (Model
681 Ion Beam Coater, Gatan, Pleasanton, CA). The entire surface of each specimen was
examined with a field emission scanning electron microscope (JEOL 7401F; JEOL, Tokyo,
Japan).
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2.7 In vitro Biofilm Analysis of S. aureus Isolates
S. aureus clinical isolates from MEEI Clinical Laboratory and two laboratory biofilm-
positive and biofilm–negative strains were screened for biofilm formation by a static
microtiter plate biomass assay using a crystal violet stain [30]. Overnight S. aureus cultures
were diluted 100-fold in non-selective media with various carbohydrate sources and
aliquoted into 96-well polystyrene flat-bottomed microtiter plates at 0.2 mL per well
(Corning Life Sciences, Corning, NY). After 24, 48, or 96 h at 37°C, the wells were washed
three times with phosphate-buffered saline (PBS) and stained with crystal violet. Eluted
crystal violet absorbance at 595 nm was measured by spectrophotometry (Tecan GENios
microplate reader, Phoenix Research Products, Research Triangle Park, NC). Experiments
were performed in triplicate and repeated three times; the data were then averaged. The
mean absorbance value obtained from media control well was deducted from all the test
absorbance values. A representative biofilm robustness grading system was assigned to each
strain under different growth conditions (Table 1).
2.8 Screening Different PEI Variants for S. aureus Biofilm Formation Inhibition
DMPEI branched and linear variants [16,19] painted on PMMA were compared using the
aforementioned representative robust biofilm-forming ocular isolates and S. aureus biofilm
laboratory strains. For covalent modifications of HMPEI, only linear PEIs were used.
Cultures were grown as above in BHI with 2% sucrose, diluted 100 fold, and 1 mL was
aliquoted into 24-well tissue culture plates (Corning Life Sciences) with each well
containing a 1-cm disc. Plates were incubated overnight without shaking at 37°C, and
biomass was measured by crystal violet staining assay.
2.9 In vitro Human Corneal Epithelial Cell Cytotoxicity Assays
Telomerase-immortalized human corneal-limbal epithelial (HCLE) cells were obtained from
Dr. I. Gipson (Schepens Eye Research Institute, Boston, MA) and plated at 2 ×104 cells/cm2
in 24-well tissue culture plates (Laboratory-Tek, Naperville, IL) in keratinocyte serum-free
medium (K-SFM; Invitrogen-GIBCO, Carlsbad, CA) at 37°C in a 5 % CO2 [31]. After
stratification of the corneal cells [31], 1-cm PMMA and HMPEI-PMMA discs were placed
on the apical epithelial cells, and cell surface damage was assessed with rose bengal stain
[31]. Morphological and cytotoxicity experiments were performed in triplicate on three
separate days. Phase contrast morphological assessment was with an inverted light
microscope (Eclipse TS100/100-F Nikon, Tokyo, Japan). Micrographs were taken with a
digital camera (SPOT Insight Fire Wire; Diagnostic Instruments, Sterling Heights, MI).
Quantitative assessment of cell cytotoxicity was performed measuring the cytosolic enzyme
lactate dehydrogenase (LDH) released upon lysis of HCLE cells (CytoTox96™, Promega,
Madison, WI); absorbances at 490 nm were measured. Experiments were performed in
triplicate on three separate days. Statistical analysis used unpaired two-sample equal
variance t-test (Excel TTEST, MIcrosoft).
2.10 Optical Testing
To detect any optical changes to the B-KPro Type I, both uncoated and coated devices were
assessed. The B-KPro was clamped in a black iris diaphragm mounted on the rail of an
optical bench containing a 3× and 10× objectives. The microscope was moved vis-à-vis the
B-KPro until the illuminated Snellen's chart positioned at 20 ft became sharply focused.
2.11 In vivo Toxicity Studies
All animals used in this study were treated in accordance with the Association for Research
in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and
Vision Research and were approved by the Massachusetts Eye and Ear Infirmary
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Institutional Animal Care and Use Committee (Boston, MA). Only one eye per animal was
used. The New Zealand white rabbits (Millbrook Farm Breeding Lab, Amherst, MA)
weighed between 3.5 and 5.0 kg were anesthetized with intramuscular injection of ketamine
HCl (35 mg/kg) and xylazine HCl (10 mg/kg). The BALB/c mice were 20-30 grams in
weight (Charles River Laboratories, Wilmington, MA) and received a combination xylazine/
ketamine mixture intraperitoneally (50 mg/kg).
Anesthesia was given 15 min prior to surgery. Topical proparacaine HCl 0.5% was instilled
into the conjunctival sac of the eye, and the operating area was sterilized with 5% povidine-
iodine and repeated after 5 min. Topical ophthalmic antibiotics (Polytrim™) were given
immediately pre-operatively. Animals were placed in a laterally recumbent position for
surgery.
In clinical assessment, performed by two independent observers, ten parameters were
assessed: corneal haze/infiltrate, edema, and neovascularization; conjunctival irritation/
chemosis and discharge; epithelial abnormalities; anterior chamber cells and/or flare; iritis +/
− pupil size; retroprosthetic membranes; and cataract formation. The first six parameters
were evaluated for all clinical examinations, while the last four were also evaluated by slit
lamp biomicroscopy. These were graded on a scale from 0 (absent) to 4 (most severe) in
relationship to the materials used and potential confounders (surgical wound and sutures)
with a theoretical maximum of 40 (Table 2).
Photography was performed using Nikon D90 digital single-lens reflex (SLR) camera
attached either to a Zeiss digital SLR camera adapter for the Zeiss OPMI Lumera/S7
ophthalmic surgical microscope (Carl Zeiss Surgical GmbH, Oberkochen, Germany) or
directly to Topcon slit lamp microscope (Kogaku Kikai, Tokyo, Japan).
Immediately after euthanasia, animal eyes were enucleated and fixed in neutral buffered
formalin, dehydrated, embedded in paraffin, sectioned, and stained with hematoxylin and
eosin.
2.11.1 Intrastromal disc reactivity model—In BALB/c mice, a cornea incision was
made with a Super Sharp blade, and a lamellar corneal micropocket was created using a
Graefe microdissecting knife. Either PMMA or HMPEI-PMMA 1- mm discs were placed
intrastromally in one eye of each animal. The corneal wound was closed with one 10-0
nylon suture in the earlier pilot experiments. In subsequent experiments, the corneal wound
was left unsutured. A partial tarsorrhaphy with one 8-0 suture was performed on all animals.
One dose of antibiotics pre-operatively and immediately postoperatively was given. No
post-operative antibiotics or topical steroids were administered. (n = 4 groups)
In the New Zealand white rabbit, a cornea incision in the periphery of the cornea was made
with a Super Sharp blade. A lamellar corneal micropocket was tunneled to the corneal center
using a 2.0-mm angled, bevel-up crescent microsurgical knife. Comparative parent PMMA
or HMPEI-PMMA discs (3.0 and 1.5 mm in diameter) and of parent Ti or HMPEI-Ti discs
(6-4 ELI; 3.0 mm in diameter) were placed intrastromally in one eye of each animal. The
corneal wound was closed with two 10-0 nylon sutures in the earlier pilot experiments;
subsequently, it was left unsutured with lengthening of the corneal tunnel pocket. A partial
tarsorrhaphy with three 6-0 sutures was performed on all animals and removed by the third
day. One dose of polymyxin B/trimethoprim pre-operatively, immediately postoperatively,
and daily for two subsequent postoperative days was given; no steroids were given (3-mm
discs, n = 4 groups; 1.5-mm discs, n = 3 groups).
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2.11.2 Anterior chamber disc reactivity model in the rabbit—A corneal incision
was made through the cornea into the anterior chamber using a Super Sharp blade. PMMA
and HMPEI-PMMA discs, 3 mm in diameter, were placed into the anterior chamber. The
corneal wound was closed with two 10-0 nylon sutures and removed within one week.
Immediately post-operatively and daily for two subsequent days, topical antibiotic
polymyxin B/trimethoprim ophthalmic solution and a topical steroid, prednisolone acetate
1% ophthalmic suspension, were given. (n = 1 set)
2.11.3 Keratoprosthesis front piece intrastromal-anterior chamber reactivity
model in the rabbit—To assess reactivity in the two major eye compartments that the B-
KPro resides in (corneal stroma and anterior chamber) and to enable evaluation in the
anterior chamber without floating or uncontrolled attachment to adjacent tissues, we
developed a two-compartment eye model using differently sized B-KPro front pieces, B-
KPro-FP-L (4.75-mm front plate/3.3-mm stem diameter) and B-KPro-FP-S (2.7-mm front
plate/1.5-mm stem diameter). The rabbit cornea was dissected vertically to 50% depth using
a Super Sharp blade. A corneal lamellar dissection was performed to create a semi-circle
area. The cornea was flapped over but remained attached, and either a 3.0-mm or a 1.5-mm
trephine opening was made centrally in the dissected cornea. The front plate was placed at
50% depth in the dissected corneal stroma with extension of the stem into the anterior
chamber of the rabbit's eye. The corneal flap was pulled over the B-KPro front piece and
sutured in place using six 10-0 nylon sutures. Immediately post-operatively and daily for
two subsequent days, topical antibiotic polymyxin B/trimethoprim ophthalmic solution and a
topical steroid, prednisolone acetate 1% ophthalmic suspension, were given. (B-KPro-FP-L,
n = 1; B-KPro-FP-S, n = 2)
2.11.4 B-KPro Type I with corneal autograft reactivity model in the rabbit—The
rabbit's cornea was cut with an 8.5 mm trephine blade and the corneal button was excised
with corneal scissors. The autograft cornea was placed in a Teflon well, and a 3.0 mm
trephine opening was made with an Acu-Punch centrally. The keratoprosthesis front part
was placed upside-down, the corneal graft was slid over the stem, and the backplate was
positioned over the stem and lightly screwed on until resistance was met. Viscoelastics and
the titanium C-locking ring were not used as in routine B-KPro surgeries to avoid
confounding material variables. Finally, the graft with its prosthesis was placed in the
trephine opening. The surgical wound was closed with 12 interrupted 10-0 black
monofilament nylon sutures equally spaced, and the knots were buried. PolymyxinB/
trimethoprim drops but no steroids were given during the procedure, and no contact lens was
placed. A lateral partial tarsorrhaphy using three interrupted 6-0 coated Vicryl sutures were
placed and removed within three days. Immediately post-operatively and daily until one
week prior to the end of the experiment, topical antibiotic polymyxinB/trimethoprim
ophthalmic solution was given. A topical steroid, prednisolone acetate 1% ophthalmic
suspension, was given immediately post-operatively and daily for one month in the pilot
PMMA B-KPro only experiment and daily for 7 post-operative days in the HMPEI-PMMA
compared to PMMA experiment. (PMMA B-KPRo, n = 2; HMPEI-PMMA B-KPro, n = 1)
2.11.5 Contact lens corneal epithelium reactivity model in the rabbit—Due to
the epithelial overgrowth seen in the B-KPro model above and to assess the isolated
epithelium's tissue response to HMPEI-coated materials, two different contact lenses were
evaluated. The Kontur Precision Sphere (45% methafilcon, 55% water) is an extended wear
soft clear bandage contact lens used for B-KPro [32]. The base diameter was 16 mm with an
8.6 - 9.8 mm base curve. In addition, a daily wear single use contact lens (Focus Dailies)
composed of nelfilcon A (13.8 mm, 8.6 mm base curve) was used. (methafilcon contact lens,
n = 3 sets; nelfilcon A contact lens, n = 3 sets)
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Contact lenses were sterilized with ethylene oxide in a dry state and rehydrated with BSS
solution for 15-30 min prior to placement. The rabbit's eye was sterilized with 5% povidone-
iodine for 5 min and rinsed with sterile BSS solution to remove residual povidone-iodine.
The contact lens or contact lens fragments were placed on to the corneal surface. A ¾ partial
tarsorrhaphy with four 6-0 Vicryl sutures were used to prevent loss of the contact lenses
from the rabbit's cornea surface. In a pilot study, the eye was examined at 2, 7, 14, and 22
days with re-suturing of the partial tarsorrhaphy. In subsequent experiments, the cornea
surface was only examined at 22 days to minimize movement of the contact lenses. Any
corneal defects were further examined with fluorescein (Flour1-StripA′1″, Wyeth-Ayerst
Laboratories, Philadelphia, PA).
3. Results
3.1 In vitro Studies
Since there is suggestive evidence that ocular infection may be caused by a subset of
organisms that possess virulence traits [20-22] and because media composition affects in
vitro biofilm production [33], we evaluated S. aureus laboratory strains and clinical isolates
for biofilm production under various media and growth conditions (Table 1). As others [34],
we found that S. aureus ocular isolates formed biofilms variably under different conditions.
We selected those ocular-associated strains that formed robust biofilms under diverse in
vitro media and growth conditions (Table 1) for further studies. Our hyperbiofilm laboratory
mutant, MN8m, avidly self-adhered but its adherence to polystyrene was variable depending
on growth conditions. Since our ocular and mucosal surface isolates formed biofilms most
robustly in BHI-2% sucrose, this medium was used for subsequent studies.
We examined both branched and linear DMPEIs. Unfortunately, both branched and linear
DMPEIs painted on the surface of PMMA chipped under our biofilm growth conditions.
Based on this finding and results of previous studies [19], in all subsequent experiments
HMPEI (C6) covalently attached to PMMA and titanium was employed.
Three different ocular-associated S. aureus isolates, a hyperbiofilm strain (MN8m), and a
biofilm-defective strain (MN8mΔica(x02237)tet) were grown on both HMPEI-coated and
parent materials (1-cm PMMA and Ti discs) for 24 h and 6 days. As seen in Figs. 2A and 2B
for HMPEI-PMMA and PMMA (similar data for titanium not shown), marked inhibition of
bacterial biofilms in all clinical isolates was observed by confocal laser scanning
microscopy. There was >99% inhibition of both the laboratory-derived MN8m [14,25] and
the biofilm-defective MN8m(Δ) strains by the derivatized materials. Due to the
autofluorescence of acridine orange stained HMPEI-coated materials, a third channel was
added (633 nm, Cy6-blue) for qualitative assessment. An accurate measurement of biofilm
thickness and height was limited by the focal length required to measure mature biofilms
grown on 150-200 micron discs within a tissue culture dish and the autoflourescence of
HMPEI itself. Nevertheless, there was at least a 4- to 8-fold inhibition in S. aureus biofilm
thickness on HMPEI-PMMA (Fig. 2A) compared to that on parent PMMA (Fig. 2B). There
was likewise a 2- to 4-fold less biofilm formation on HMPEI-Ti materials compared to that
on parent Ti (note that our S. aureus strains preferentially grew biofilms on parent PMMA
compared to parent Ti).
Biofilm formation and adherence by the three ocular S. aureus isolates, a hyperbiofilm strain
(MN8m), and a MN8mΔ ica(x02237)tet defective biofilm grown on HMPEI-PMMA discs
compared to those on unmodified PMMA discs were then examined by SEM. The inhibition
of biofilm formation persisted in all isolates after 6 days of continuous static growth on
HMPEI-PMMA (Fig. 2C), while the bacteria grown on parent PMMA continued to
accumulate more mature biofilm structures (Fig. 2D). In addition, lysis of bacterial cell
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walls resulting in sickled shaped cells was observed on HMPEI-PMMA discs (Fig. 2C). The
hyperbiofilm forming strain (Fig. 2E) and the biofilm-defective strain showed >99% biofilm
inhibition when grown on HMPEI-PMMA discs compared to unmodified PMMA discs. The
only bacteria that remained intact appeared to be suspended in a bacterial-derived matrix and
not in contact with the coated HMPEI-PMMA material below (Fig. 2E).
To screen for cytotoxicity in vitro, HMPEI-PMMA discs were compared to the uncoated
PMMA counterparts by placing both on confluent immortalized human corneal limbal
epithelial (HCLE) cells. HMPEI-PMMA exhibited no additional toxicity (Fig. 3A) in
comparison to PMMA (Fig. 3B) for HCLE cells. Similar morphological disruption of the
stratified HCLE cells after placement of unadhered discs was seen in both HMPEI-PMMA
and parent PMMA discs after the first 48 h, and similar epithelial cell growth and recovery
was seen on HMPEI-PMMA and PMMA discs comparable to the HCLE cell (no disc)
control by 72 h (Figs. 3A, 3B, and 3C). Rose bengal staining demonstrated equal
stratification of HCLE cells grown on HMPEI-PMMA and PMMA discs and comparable to
HCLE cell (no disc) control (data not shown).
Quantitative assessment of lysed HCLE cells by a lactate dehydrogenase release cytotoxicity
assay showed no additional cell cytotoxicity in the case of HMPEI-PMMA discs compared
to PMMA controls at 24 h, and there was significantly less cytotoxicity seen on HMPEI-
PMMA discs compared to the control PMMA discs by 48 and 72 h (Fig. 3D) (p values <
0.0001 and <0.01, respectively). Less cell cytotoxicity was seen with the HCLE cell only
(no disc) control compared to either HMPEI-PMMA or PMMA at 24 and 48 hours, but
more cell cytotoxicity was measured at 72 hours due to cell crowding and nutritional
limitations (data not shown).
Finally, it is noteworthy that the covalent attachment of HMPEI to B-KPro did not alter its
optical clarity or refractive optical power.
3.2 In vivo Evaluation
Since the B-KPro is predominantly in contact with the corneal stroma, this model was
designed to evaluate for any toxicity within the corneal stroma of the rabbit (Fig. 4A). There
was less corneal inflammatory response with HMPEI-PMMA discs than with parent PMMA
ones in both BALB/c mice (data not shown; N = 4 for 1-mm discs) and New Zealand white
rabbits (Fig. 5; N = 4 for 3-mm PMMA discs; N = 3 for 1.5-mm PMMA discs). There was
also less corneal edema, corneal haze, neovascularization, and conjunctival irritation and
discharge seen with HMPEI-PMMA 3-mm discs (Fig. 5A) compared to the control ones
(Fig. 5B) intrastromally (Table 2). Histopathology revealed that intrastromal HMPEI-
PMMA discs showed no more inflammation than unmodified PMMA ones, whether they
were surgically removed or spontaneously extruded.
HMPEI-Ti discs (Fig. 5C; N = 4) when compared to parent Ti controls (Fig. 5D; N = 4)
exhibited no more reactivity by clinical assessment. The histopathologic examination of the
titanium discs after 61 days showed an excellent host stromal tolerance both with HMPEI
coating and without (Figs. 8A and 8B, respectively). There was no evidence of
inflammation, vascularization, or active scar formation (Figs. 8A and 8B). Scanning electron
microscopy of the HMPEI-Ti discs and parent Ti discs (Figs. 9A and 9B, respectively, 25X,
inset 500X) extracted from the corneal stroma at 61 days revealed no inflammatory response
to either. In addition, denser, more compact, and confluent cells were seen on HMPEI-Ti
discs (Fig. 9A) than on parent Ti discs (Fig. 9B).
Note that HMPEI-PMMA discs were no more reactive than the parent PMMA ones when
placed in the anterior chamber of the eye. Although the reactivity was greater in the anterior
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chamber model than in the intrastromal one (data not shown), the unpredictable free-floating
movement of the discs within the anterior chamber limited this model's usefulness.
Using a Keratoprosthesis front piece (KPro-FP) placed into the corneal stroma and the stem
extending into the anterior chamber (Fig. 4B), the reactivity in the rabbit was assessed over
time. On post-operative day 2, HMPEI-PMMA KPro-FP (Fig. 6A) appeared similar to
control PMMA KPro-FP (Fig. 6B), with the exception of the onset of iritis in PMMA KPro-
FP. There was less corneal edema, haze, neovascularization, conical ectasia, and
conjunctival discharge in HMPEI-PMMA KPro-FP (Fig. 6C) compared to parent PMMA
KPro-FP (Fig. 6D) by post-operative day 30. By three months, these changes progressed
further in the PMMA KPro-FP (Fig. 6F, Table 2), while the HMPEI-PMMA KPro-FP
remained relatively unchanged (Fig. 6E, Table 2). Small retroprosthetic membranes formed
on both PMMA and HMPEI-PMMA stems. Front pieces were surgically extracted on post-
operative day 105. The histopathologic examination of PMMA front pieces with and without
HMPEI coating revealed different host stromal responses. The HMPEI-coated specimen
showed a fibroblast reparation response surrounding the posterior aspect of the implant front
piece without inflammation or vascularization (Fig. 8C). The non-coated front piece
displayed moderate acute inflammation with minimal microvascularization (Fig. 8D). SEM
showed denser, more compact and confluent cells attached to HMPEI KPro-FP (Fig. 9C), as
compared to looser, disorganized cells attached to the control PMMA KPro-FP (Fig. 9D).
To assess what effect the HMPEI coating may have on the epithelial layer, stroma,
endothelium, anterior chamber, and the corneal graft healing, a human-sized B-KPro Type I
with a corneal autograft was placed in a rabbit eye with less topical steroid usage. When
HMPEI-PMMA B-KPro (Figs. 7A and 7C) is compared to the uncoated PMMA B-KPro at
postoperative day 69 (Figs. 7B and 7D) in the rabbit, less corneal edema, haze, and
conjunctival discharge is observed (Table 2). As seen with the KPro-FP model on the side
view, the control PMMA B-KPro underwent conical ectasia of the cornea (Fig. 9D) that was
not observed in the HMPEI B-KPro in the rabbit. This conical reshaping of the cornea is
unique to the rabbit and not seen in humans with a B-KPro. In addition, epithelial growth on
the front piece was seen with HMPEI-PMMA B-KPro (Figs. 7A and 7C), while it did not
occur on control PMMA B-KPro surfaces (Figs. 7B and 7D) in the rabbit (nor does it occur
normally on PMMA front piece surfaces in humans [35]). Even with mechanical removal of
the epithelial growth, the epithelium re-grew within one month.
To evaluate the epithelial overgrowth seen on HMPEI-PMMA B-KPro, we determined
whether this was a HMPEI-specific response by covalently attaching HMPEI to two
different contact lenses (methafilcon and netilicon) and comparing the results to those seen
with the parent materials. We did observe epithelial overgrowth and possibly enhanced
adherence with associated epithelial defects with both HMPEI-netilicon and HMPEI-
methafilcon contact lenses by day 22 in the rabbit. This phenomenon was not seen in the
control contact lenses in the rabbit. On histopathological examination, there was epithelial
overgrowth occurring where the contact lens space was (not shown). SEM demonstrated the
normal mosaic of light, medium, and dark epithelial cell organization (Fig. 9E) and the
presence of microplicae (Fig. 9F).
The drying effects associated with our covalent modification may have adversely affected
the high water content and/or decreased O2 permeability of the soft contact lenses. Note,
however, that the purpose of this additional evaluation was to assess HMPEI-associated
epithelial overgrowth on material(s) known to reside on the epithelial surface that are
normally resistant to epithelial overgrowth, and not to determine HMPEI's feasibility for
contact lens use.
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4. Discussion
Immobilized HMPEI exerts its antimicrobial effects by long hydrophobic polycationic
chains that are able to penetrate and lyse the cell membranes/walls of microorganisms [14,
15]. This contact-dependent killing has been demonstrated for planktonic bacteria, as well as
viruses and fungi [17-19], but heretofore not for bacterial biofilms that are the major cause
of device-associated infections [3] and naturally resistant to antimicrobial agents [5]. Using
large inocula (>107) of S. aureus biofilm-forming clinical isolates, we determined herein that
the surface derivatization with the hydrophobic polycation brought about a drastic reduction
of biofilm formation and a sustained bacterial killing over at least one week in continuous
growing cultures in vitro.
The function of B-KPro, an artificial cornea, depends on its optical clarity and refraction. By
optical bench testing, we determined that covalent modification with HMPEI did not alter B-
KPro's shape, clarity, refractive index, or image-forming quality. We also determined that
HMPEI covalently attached to PMMA conferred no additional cell cytotoxicity or abnormal
morphological changes on immortalized human corneal epithelial cells (HCLE), compared
to those observed with control PMMA. There were no observable untoward effects on
epithelial cell attachment, stratification, differentiation, or proliferation, as compared to
PMMA itself. Despite the inherent limitations of 2-D tissue culture models in the study of 3-
D materials, we believe that it served as a useful screen for cytotoxic effects of comparative
materials with similar physical properties [36]. The results obtained herein support
previously reported lack of toxicity with monkey kidney cells [16].
In multiple eye compartments in the rabbit in vivo, there was no more host tissue reactivity
or inflammation observed with HMPEI-derivatized materials, as compared to the controls,
observed by clinical assessment, histopathologic examination, and SEM. In fact, in both the
intrastromal-anterior chamber model and the B-KPro model, the clinical tissue reactivity
(corneal swelling and neovascularization) appeared less by the first week post-operatively
with HMPEI-PMMA materials than with the uncoated controls. Also, by histopathologic
examination and SEM, HMPEI-coated materials showed no more inflammation and more
continuous cellular coatings without conspicuous debris than the parent materials.
The B-KPro front plate is composed of PMMA that normally inhibits epithelial overgrowth
over the polished optical center in both humans and rabbits. Interestingly, we observed
epithelial overgrowth on HMPEI-coated PMMA B-KPro not seen on the uncoated one.
Although this overgrowth may obscure vision and is generally undesirable [35], organized
corneal epithelial growth and differentiation might form a smooth refractive surface and a
protective tight junctional barrier that prevents decreases in net fluid transport out from the
stroma and corneal penetration by pathogens [37]. Thus epithelial overgrowth on the B-
KPro front plate may be of value in prevention of inflammation and infection, particularly in
resource-poor areas of the world, and warrants further investigation.
The results of the in vivo biocompatibility evaluations conducted in this work are further
strengthened by the fact that the rabbit eye is generally more sensitive than the human eye
[39]. The rabbit cornea is thinner with a steeper curvature and is more susceptible to
evaporative damage because of a slower blink frequency than a human eye [38]. It also has a
heightened tissue response to minor surgical procedures, foreign materials, drugs, or
chemicals [38]. Another factor strengthening our findings is that topical corticosteroids were
given only for a few days postoperatively; standard clinical postoperative regimens might
have masked inflammation in our rabbit experiments. In addition, the rabbit eye readily
extrudes foreign material, limiting long-term studies beyond a few months [39]. Thus we
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believe that the present work is an important step toward testing these HMPEI-coated
materials in humans.
5. Conclusions
HMPEI covalently attached to B-KPro materials inhibits biofilm formation by S. aureus.
The immobilized hydrophobic polycation confers no additional toxicity or reactivity
compared to the control in vitro or in vivo in enucleated eyeballs in the adjacent corneal
stroma, anterior chamber, or iris. Because it is easily observable and the prosthetic material
can be easily removed or exchanged, the B-KPro may represent an ideal format for testing
these antimicrobial coatings in humans.
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Figure 1.
(A) Schematic diagram of the B-KPro composed of optical quality PMMA shaped like a
collar-button and implanted into a corneal graft secured with a titanium locking ring. (B)
Photograph of the B-KPro composed of PMMA. (C) Photograph of the B-KPro in a corneal
allograft implanted in a patient and secured by 16 sutures. This patient had three previous
standard corneal graft failures; visual acuity is now 20/25. (D) Chemical structure of long-
chained, linear N,N-hexyl,methyl-polyethylenimine (HMPEI).
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Figure 2.
(A and B) Confocal laser scanning micrographs of S. aureus derived from an eye canniculus
infection (MEEI-IB013) after 20 h of static culture on a disc in vitro. S. aureus grown on
HMPEI-PMMA discs shows few colonies or small microcolonies (A), while the bacteria
grown on control PMMA discs forms thick, confluent biofilm structures (B). Bacteria
appear orange (1 micron in size) (acridine orange stain; three-channel combination of 488,
568, and 633 nm) (63X). (C, D) Scanning electron micrographs of S. aureus derived from a
keratitis infection (MEEI-IB001) after 6 days of continuous static growth in vitro. S. aureus
grown on HMPEI-PMMA discs shows single or small microcolonies with lysis of bacterial
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walls (1500X); inset shows higher magnification (5000X) of bacterial cell lysis (C).
Confluent, mature bacterial biofilms are seen on control PMMA discs (1500X) (D). (E)
SEM of laboratory-derived hyperbiofilm forming S. aureus strain (MN8m) after 6 days of
continuous static growth on HMPEI-PMMA discs in vitro. S. aureus bacterial colonies are
seen suspended on bacterial-derived extrapolysaccharide matrix, while no bacteria are seen
on the HMPEI-PMMA disc below (1500X). Inset shows a higher magnification (4000X) of
bacterial colonies suspended over HMPEI-PMMA material with lysis of bacterial walls on
contact with it. (F) SEM of a no-bacteria control of HMPEI-PMMA discs. The rough cutting
of PMMA disc is unaltered by covalent attachment of HMPEI to it (1300X).
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Figure 3.
Phase-contrast images of unstained immortalized human corneal epithelial (HCLE) cells
grown on tissue culture dishes in vitro at 72 h after the addition of (A) HMPEI-PMMA disc,
(B) control PMMA disc, and (C) no-disc control. There is no evidence of devitalization of
the epithelial cells resulting from the HMPEI coating. (D) Graph shows HCLE cell
cytotoxicity as measured by released lactate dehydrogenase associated with cell lysis. There
is no more HCLE cell cytotoxicity measured with HMPEI-coated PMMA discs than with
control PMMA ones at 24 h. There is statistically significantly less toxicity at 48 h and 72 h
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with HMPEI-PMMA discs than with control PMMA discs (p values <0.00001 and <0.01,
respectively).
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Figure 4.
Schematic diagrams of the various material models in the anterior eye of the rabbit. (A) The
disc model shows the disc residing intrastromally in the cornea. (B) The KPro Front Piece
(KPro-FP) model shows the front piece in the corneal stroma with its stem protruding into
the anterior chamber. (C) The B-KPro model shows the PMMA front plate resting on the
corneal epithelium with the PMMA stem extending through a corneal autograft, through a
backplate, into the anterior chamber, and secured by a locking C-ring.
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Figure 5.
Representative clinical photographs of 3-mm discs placed intrastromally within the cornea
of the New Zealand white rabbit. (A) HMPEI-coated PMMA disc is compared to (B) control
PMMA disc at 38 days postoperatively. (A) There is only a faint outer disc haze seen with
the HMPEI-PMMA disc. (B) A white corneal nontransparent haze with corneal
neovascularization is seen over the control PMMA disc. There is less corneal tissue
reactivity with HMPEI-coated PMMA discs compared to control PMMA discs.
Representative clinical photographs of (C) HMPEI- coated titanium disc placed
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intrastromally compared to (D) control Ti counterpart at 61 days postoperatively shows
minimal tissue reactivity and similar clinical features in both groups.
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Figure 6.
Clinical photographs of comparative KPro-FP placed intrastromally with the extension into
the anterior chamber of the eye of a New Zealand white rabbit shown at three representative
time points. (A, B) At post-operative day 2, HMPEI-PMMA KPro-FP (A) rabbit eye shows
a lamellar flap with 6 sutures and mild post-operative corneal swelling similar to control
PMMA KPro-FP (B) showing the same clinical features. (C, D) At one month post-
operatively, HMPEI-PMMA KPro-FP (C) shows minimal corneal swelling, only a mild
neovascularization at the surgical wound site, and no corneal ectasia, while PMMA KPro-FP
(D) shows moderate corneal edema, corneal neovascularization has advanced to the front
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plate, and there is mild corneal ectasia. (E, F) By three months post-operatively, HMPEI-
PMMA KPro-FP (E) remains quiescent with minimal corneal reactivity, neovascularization,
and conical ectasia compared to the uncoated control PMMA KPro-FP (F) that shows
moderate corneal swelling, extension of the corneal neovascularization over the front piece,
and progressive conical ectasia.
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Figure 7.
Clinical photographs of an anterior and profile view of comparative B-KPro Type I with a
corneal autograft in the New Zealand white rabbit eye at 69 days post-operatively. (A, C) In
the HMPEI-PMMA B-KPro rabbit eye, there is no mucous accumulation seen behind the
front plate, but there is epithelial cell growth over the front plate, moderate
neovascularization, and mild conical ectasia. (B, D) In the control PMMA B-KPro rabbit
eye, there is visible accumulation of cellular debris, mucous in a space behind the front
plate, moderate-severe corneal neovascularization, and corneal ectasia.
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Figure 8.
Representative histopathology of a (A) HMPEI-Ti disc is shown compared to (B) control Ti
disc at 61 days post-operatively. There is minimal cellular reactivity at the edges of the disc
(arrow) and no significant difference between the two groups (hematoxylin and eosin stain;
A ×100, B ×100). Histopathology shown for the HMPEI-PMMA KPro-FP (C) compared to
control PMMA KPro-FP (D), at post-operative day 37. (C) HMPEI-PMMA KPro-FP shows
minimal inflammatory response and a fibroblastic response is present posterior to the cavity
(c) that contained the explanted KPro-FP. (D) The uncoated PMMA KPro-FP shows a
moderate acute inflammatory response (arrows) surrounding the cavity (c). There is minimal
microvascularization (V) (hematoxylin and eosin stain; C ×100, D ×200; DM, Descemet's
membrane; EN, endothelium; EP, epithelium).
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Figure 9.
Representative scanning electron micrographs of HMPEI-titanium disc (A) compared to a
control titanium disc (B) extracted from the corneal stroma after 61 days in the rabbit in
vivo. (A) Cells attached to the HMPEI-Ti discs appear smoothly confluent (25X). A higher
magnification inset shows a dense “basketweave” of epithelial cells on the HMPEI-Ti disc
(500X). (B) Cells attached to the control Ti discs demonstrate a less contiguous and more
disorganized covering on the uncoated disc (25X). The higher magnification inset shows
rolled up edges of discontinuous stromal cells on the control Ti disc (500X). SEMs of (C)
HMPEI-PMMA KPro-FP compared to (D) control PMMA KPro-FP surgically extracted at
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post-operative day 105. (C) Micrograph shows denser, more compact stromal cells adherent
to HMPEI-PMMA KPro-FP (25X). A higher magnification inset shows a dense
“basketweave” of epithelial cells (500X). (D) There is looser, discontinuous cellular material
on the PMMA KPro-FP (25X). The higher magnification inset shows red blood cells in a
capillary loosely attached to stromal cells on the front piece (500X). SEMS of (E) HMPEI-
coated netilicon and (F) HMPEI-methafilcon contact lenses at 22 days after placement on
the rabbit cornea. (E) Micrograph shows organized, smoothly confluent normal mosaic of
light, medium, and dark epithelial cells adhering to the HMPEI-coated netilicon contact lens
(1000X). (F) A higher magnification shows normal epithelial cell microplicae on the
HMPEI-coated methafilcon contact lens (5000X).
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